Xylitol

木糖醇

Report date: 2026/02/26 20:00:22
NME

Base Information

Drug NameXylitol
Drug Alias NameN/A
ClassificationSmall molecules > Carbohydrate
Mechanisms of ActionGlycosylation stimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Persian Gulf SyndromePain +[18] 
Global Approved IndicationsDiabetes Mellitus
Approved Indications in ChinaDiabetes Mellitus
Original Approved Country/TerritoryMainland China
Original Approved Date1985/01/01
Country/TerritoryUnited StatesItalyEgypt +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesCarolinas Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesThe Brigham and Women's HospitalCairo UniversityBoston Children'S Hospital +[5] 
Inactive CompaniesAugusta UniversityKuwait UniversityDuke University +[11] 
Active IndicationsPainHypersensitivityDiabetes Mellitus +[7] 
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Persian Gulf SyndromeFatigue +[11] 

Other Information

ATC CodeA01AA
Related LinksWikipedia